Strategy to Adapt Botulinum Toxin Doses in Dystonia

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06386848

Enrollment

100

Registered

2024-04-26

Start date

2024-05-01

Completion date

2024-06-01

Last updated

2024-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dystonia

Brief summary

The study is designed to observ and collect the doses of botulinum toxin injected in dystonia in different centres to compare the initial dose and the dose recommended. We we ll study the increase of the dose injected over the time, the side effects... The hypothesis is that we inject smaller doses than we could regarding the recommandations

Interventions

DRUGBotulinum toxin

Botulinum toxin doses injected in dystonia

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* patients over 18 years old followed for dystonia and treated with botulinum toxin

Exclusion criteria

* first dose of botulinum toxin not available

Design outcomes

Primary

Measure	Time frame	Description
First dose of botulinum toxin injected, U	30 years	dose injected in U

Secondary

Measure	Time frame	Description
Effective dose of botulinum toxin	30 years	dose injected in U
Side effects	30 years	diplopia, ptosis and others

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026